Common Reasons for Injection Site Bruising While nicking a capillary is often a matter of chance, several factors can increase the likelihood of seeing a bruise after your weekly dose
GIAI after short bursts of glucocorticoids (714 days) has been infrequently reported, particularly in patients with chronic obstructive pulmonary disease who receive frequent short bursts of glucocorticoids and patients with malignancies who receive bursts of dexamethasone to mitigate chemotherapy-related nausea
By early 2025, Novo estimated roughly 30% of all semaglutide volume in the U.S
Patients were included if they met all the following criteria: (1) new-onset type 2 diabetes diagnosed between 1 January 2006 and 31 December 2015, according to International Classification of Diseases, Revision 10 (ICD-10) code (Additional file 1: Table S1) or use of antidiabetic medications by the Anatomical Therapeutic Chemical (ATC) classification codes (Additional file 1: Table S2)
Catching changes early with data makes adjustments much easier
Moxit Shah Endocrinologist, Ahmedabad If you are looking for expert guidance on: Medical weight loss GLP-1 therapy Tirzepatide (Mounjaro) Semaglutide (Ozempic/Wegovy) Diabetes management Thyroid disorders PCOS Hormonal disorders Book your consultation today
